Evidence map›Paper›PMID 26835699›Full record

ArticleMolecular medicine (Cambridge, Mass.)2016

Combined Administration of Human Ghrelin and Human Growth Hormone Attenuates Organ Injury and Improves Survival in Aged Septic Rats.

Weng-Lang Yang, Gaifeng Ma, Mian Zhou, Monowar Aziz, Hao-Ting Yen, Spyros A Marvropoulos, Kaie Ojamaa, Ping Wang

Open access · goldAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Ghrelin induced by ultraviolet B exposure promotes the restoration of diabetic cutaneous wound healing.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Ghrelin as an Anti-Sepsis Peptide: Review.Frontiers in immunology · 2020
    Review
  8. Physiological Effect of Ghrelin on Body Systems.International journal of endocrinology · 2020
    Review
  9. Cannabinoid CBInflammation · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Weng-Lang YangTheraSource LLC, Manhasset, New York, United States of America.
Gaifeng MaTheraSource LLC, Manhasset, New York, United States of America.
Mian ZhouCenter for Immunology and Inflammation, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America.
Monowar AzizCenter for Immunology and Inflammation, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America.
Hao-Ting YenTheraSource LLC, Manhasset, New York, United States of America.
Spyros A MarvropoulosHofstra Northwell School of Medicine, Hempstead, New York, United States of America.
Kaie OjamaaCenter for Immunology and Inflammation, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America.
Ping WangCenter for Immunology and Inflammation, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America.
Feinstein Institute for Medical Research · USTheraSource (United States) · USHofstra University · US

Funding

Preclinical Testing of Human Ghrelin and Growth Hormone for Sepsis in the ElderlyR44AG046994 · NIA · THERASOURCE, LLC · PI YANG, WENG-LANG · 2016 to 2018
$1.6M
PRECLINICAL TESTING OF HUMAN GHRELIN AND GROWTH HORMONE FOR SEPSIS IN THE ELDLYR43AG046994 · NIA · THERASOURCE, LLC · PI YANG, WENG-LANG · 2014 to 2014
$225k
NIA NIH HHS R43 AG046994
6 · The paper itself

Abstract

Sepsis is a major healthcare concern, especially in the elderly population. The use of an animal model closely resembling clinical conditions in this population may provide a better prediction in translating bench studies to the bedside. Ghrelin inhibits sympathetic nerve activity and inflammation in young septic animals; however, aged animals become hyporesponsive to ghrelin. In this study, we evaluated the efficacy of combined human ghrelin and growth hormone (GH) for sepsis treatment in the elderly utilizing a clinically relevant animal model of sepsis. Male Fischer 344 rats 22 to 24 months old were subjected to cecal ligation and puncture (CLP). Human ghrelin plus GH or vehicle (normal saline) was administered subcutaneously at 5 h after CLP. At 20 h after CLP, blood and tissue samples were collected for various analyses. Combined treatment attenuated serum levels of lactate, lactate dehydrogenase, creatinine, blood urea nitrogen, interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in aged septic rats. The integrity of the microscopic structure in the lungs, liver and kidneys was well preserved after treatment. Expression of IL-6, TNF-α, macrophage inflammatory protein-2 and keratinocyte-derived chemokine as well as myeloperoxidase activity and caspase-3 activation were significantly reduced in the lungs and liver of treated rats. Moreover, treated rats showed an improvement in cardiovascular function and increased expression of ghrelin receptor and

Identifiers

PMID26835699
PMCPMC5004717
OpenAlexW2405395633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.